SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1183Wilder, The only real concerns raised at the AC meeting were the occasional sidBiomaven-12/3/2001
1182Peter, you are probably right. But I could never nail down whether the safety ikeokalani'nui-12/3/2001
1181Wilder, I think the risk of complete non-approval is very low. The only real riBiomaven-12/3/2001
1180I don't understand Medi buying avir. Isn't that taking on an extraordinkeokalani'nui-12/3/2001
1179Nigel, the CEPH and MEDI deals may be a signal that consolidation has finally arMark Bong-12/3/2001
1178MedImmune to Acquire Aviron in Exchange Offer Valued at $1.5 Billion GAITHERSBUnigel bates-12/3/2001
1177Cephalon to acquire drugmaker Lafon for $450 mln NEW YORK, Dec 3 (Reuters) - Binigel bates-12/3/2001
1176I agree KOSN would be the *perfect* munch for SEPR. Continue the ice theme withrkrw-12/1/2001
1175Unfortunately, it wasn't obvious to me either, beforehand (and it hasn'ttommysdad-11/30/2001
1174>> I think SEPR in a year or so should munch KOSN. << Ha! Rather Sscaram(o)uche-11/30/2001
1173DDDP is indeed an interesting thought, and not necessarily with just INCY as a pBiomaven-11/30/2001
1172DDDP, if there's a merger of equals feel/interpretation??scaram(o)uche-11/30/2001
1171<DPII> <i>an obvious next choice</i> Well not too obvious foBiomaven-11/30/2001
1170biz.yahoo.com With the CRA/AXPH deal and the LEXG/Coelacanth deal, this seems ltommysdad-11/30/2001
1169British Biotech says it's looking... news.ft.com aknahow-11/23/2001
1168In view of their recent performance, I'm wondering what INCY's business nigel bates-11/20/2001
1167<i>Exelixis will acquire Genomica in a stock-for-stock transaction valued nigel bates-11/19/2001
1166Genomica munched........ Monday November 19, 4:39 pm Eastern Time Press Releasscaram(o)uche-11/19/2001
1165Investors Business Daily 11/16 IN BRIEF blurb from biotech conference in Italy: aknahow-11/16/2001
1164Are they spreading too wide? This sound like catalytic-RNA? Which generate zeroMiljenko Zuanic-11/13/2001
1163<i>taste for private companies </i> Yes - I noticed that ABGX munchBiomaven-11/13/2001
1162ABGX seems to be getting a taste for private companies - Message 16652093nigel bates-11/13/2001
1161The watermelon was pretty expensive - even if you compare prices on a per lb basnigel bates-11/12/2001
1160<i>Whereas the biggest pharma-biotech deal in 1998 only cost Bayer $465 miBiomaven-11/12/2001
1159One has to allow for his background slightly skewing his perspective <g> -nigel bates-11/12/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News